STUDIIO-Diabetes Pilot: STUdy of Drug Insurance to Improve Outcomes of Diabetes
A Pilot Pragmatic Randomized Controlled Trial to Evaluate the Impact of Improving Access to Drugs on Type 2 Diabetes Care, Outcomes and Costs
Sponsor: Canadian Institutes of Health Research (CIHR)
Listed as NCT03804905, this NA trial focuses on Medication Adherence and Medication Compliance and remains actively recruiting participants. Sponsored by Canadian Institutes of Health Research (CIHR), it has been updated 10 times since 2026, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Jan 2025 — Present [monthly]
Not Yet Recruiting NA
-
Sep 2024 — Jan 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
-
Jan 2023 — Jan 2024 [monthly]
Not Yet Recruiting NA
▶ Show 5 earlier versions
-
Apr 2021 — Jan 2023 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Not Yet Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Oct 2019 — Nov 2020 [monthly]
Not Yet Recruiting NA
-
Feb 2019 — Oct 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Institutes of Health Research (CIHR)
- Sunnybrook Health Sciences Centre
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.